切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (02) : 200 -203. doi: 10.3877/cma.j.issn.1674-3946.2024.02.022

论著

Easy First策略在新辅助化疗后腹腔镜胰十二指肠切除术中的临床疗效研究
祝启路1, 邹佳悦1, 肖均喜1, 侍阳1,()   
  1. 1. 215000 江苏苏州,苏州大学附属第一医院普外科
  • 收稿日期:2023-06-20 出版日期:2024-04-26
  • 通信作者: 侍阳

Clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy after neoadjuvant chemotherapy

Qilu Zhu1, Jiayue Zou1, Junxi Xiao1, Yang Shi1,()   

  1. 1. Department of General Surgery, the First Affiliated Hospital of Soochow University, Shuzhou Jiangsu Province 215000,China
  • Received:2023-06-20 Published:2024-04-26
  • Corresponding author: Yang Shi
  • Supported by:
    Suzhou Science and Technology Development Plan(SLJ2021001)
引用本文:

祝启路, 邹佳悦, 肖均喜, 侍阳. Easy First策略在新辅助化疗后腹腔镜胰十二指肠切除术中的临床疗效研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 200-203.

Qilu Zhu, Jiayue Zou, Junxi Xiao, Yang Shi. Clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy after neoadjuvant chemotherapy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(02): 200-203.

目的

探究Easy First策略在新辅助化疗后腹腔镜胰十二指肠切除术(LPD)中的临床疗效。

方法

回顾性分析2019年1月至2021年12月收治的可切除或交界性可切除胰腺癌患者60例资料,所有患者均在新辅助化疗后行LPD,根据手术方法不同分为观察组(n=29例)和传统组(n=31例),观察组采用Easy First策略,术中优先处理胃、空肠和胆总管等,最后处理胰颈及胰腺钩突等顺序完成手术;传统组行传统LPD。采用SPSS 24.0完成数据分析。并发症等计数资料用[例(%)]表示,组间比较采用χ2检验;围手术期指标等计量资料用()表示,组间比较以独立样本t检验;采用Kaplan-Meier法、Log-Rank检验进行生存分析。P<0.05差异有统计学意义。

结果

观察组术中出血量显著少于传统组,引流管拔除时间短于传统组(P<0.05);两组患者手术时间、输血、淋巴结清扫数目、术后住院时间比较,差异均无统计学意义(P>0.05);观察组并发症总发生率虽低于传统组(6.9% vs. 22.6%),但组间差异无统计学意义(P>0.05);两组患者累积总生存率比较(44.8% vs. 38.7%),差异无统计学意义(Log-Rank χ2=1.437,P=0.231)。

结论

在新辅助化疗后LPD术中应用Easy First策略,可在术中及时控制出血,提高手术安全性,相比传统手术方法,更适用于新辅助化疗后局部组织粘连、炎症水肿明显的患者。

Objective

To explore the clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy (LPD) after neoadjuvant chemotherapy.

Methods

Data of 60 patients with resectable or borderline resectable pancreatic cancer treated from January 2019 to December 2021 were retrospectively analyzed. All patients received LPD after neoadjuvant chemotherapy and were divided into observation group (n=29 cases) and traditional group (n=31 cases) according to different surgical methods. Easy First strategy was adopted in the observation group. The stomach, jejunum and common bile duct were treated first, and the neck of pancreas and uncinate process of pancreas were treated last. Traditional group row traditional LPD. SPSS 24.0 was used to complete the data analysis. Complications and other statistical data were represented by [cases (%)], and χ2 test was used for comparison between groups. Perioperative indicators and other measurement data were represented by (), and inter-group comparison was conducted by independent sample t test. Kaplan-Meier method and Log-Rank test were used for survival analysis. P<0.05 was statistically significant.

Results

The intraoperative blood loss in the observation group was significantly less than that in the traditional group, and the drainage tube removal time was shorter than that in the traditional group (P<0.05). There were no significant differences in operation time, blood transfusion, number of lymph node dissection and postoperative hospital stay between the two groups (P>0.05). The total incidence of complications in the observation group was lower than that in the traditional group (6.9% vs. 22.6%), but there was no significant difference between the two groups (P>0.05). There was no significant difference in cumulative overall survival between the two groups (44.8% vs. 38.7%) (Log-Rank χ2 =1.437, P=0.231).

Conclusion

The application of Easy First strategy in LPD after neoadjuvant chemotherapy can control bleeding in time and improve surgical safety. Compared with traditional surgical methods, EASY First strategy is more suitable for patients with local tissue adhesion, inflammation and edema obvious after neoadjuvant chemotherapy.

表1 胰腺癌两种不同手术方法两组患者一般临床资料比较
表2 胰腺癌两种不同手术方法两组患者围手术期指标比较
表3 胰腺癌两种不同手术方法两组患者并发症情况比较(例)
图1 胰腺癌两种不同手术方法两组患者术后Kaplan-Meier生存曲线
[1]
Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors[J]. Nat Rev Gastroenterol Hepatol2021,18(7):493-502.
[2]
梁先春.静脉切除对门静脉受累胰腺癌根治术患者近期疗效及远期预后的影响[J/CD].中华普外科手术学杂志(电子版),2019,13(04):354-357.
[3]
刘悦泽,张太平,赵玉沛.日本胰腺学会《胰腺癌临床实践指南(2022年版)》更新解读[J].中国实用外科杂志,2023,43(07):772-776.
[4]
李征,虞先濬,徐晓武.胰腺癌新辅助化疗后行腹腔镜胰十二指肠切除术的难点及对策[J].中国实用外科杂志,2022,42(05):526-528.
[5]
张太平,刘悦泽.中国腹腔镜胰十二指肠切除术20年发展、存在问题及对策[J/CD].中华普外科手术学杂志(电子版),2021,15(03):241-244.
[6]
中华医学会外科学分会胰腺外科学组,中国医疗保健国际交流促进会胰腺病分腹腔镜胰十二指肠切除手术专家共识(附:手术流程与主要步骤)[J].中华外科杂志201755(05):5.
[7]
Gugenheim JCrovetto APetrucciani N. Neoadjuvant therapy for pancreatic cancer[J]. Updates Surg2022,74(1):35-42.
[8]
商阳阳,陶俊宇,杨佳丽,等.交界可切除和局部进展期胰腺癌行新辅助化疗的疗效分析[J].中国普通外科杂志,2023,32(03):336-345.
[9]
Ye MZhang QChen Y,et al. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis[J]. HPB(Oxford)2020,22(6):821-832.
[10]
Truty MJKendrick MLNagorney DM,et al. Factors Predicting Response,Perioperative Outcomes,and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer[J]. Ann Surg2021,273(2):341-349.
[11]
Mikulic DMrzljak A. Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy[J].World J Clin Cases2021,9(20):5398-5407.
[12]
孟庆才,王巍.胰腺癌新辅助化疗策略选择及手术时机[J].肝胆外科杂志,2022,30(01):73-75.
[13]
耿小平.关于开展腹腔镜胰十二指肠切除术的一些思考[J].中国实用外科杂志,2023,43(01):90-92.
[14]
Yamada KKawashima HOhno E,et al. Diagnosis of vascular invasion in pancreatic ductal adenocarcinoma using endoscopic ultrasound elastography[J]. BMC Gastroenterol2020,20(1):81.
[15]
He YGHuang XBLi YM,et al. Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study[J]. World J Gastrointest Oncol2022,14(9):1785-1797.
[1] 孙丕绛, 李剑波, 杨永君, 冉超, 王槐志. 腹腔镜下肠系膜上动脉优先入路扩大清扫的胰十二指肠切除术(en-bolc)[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 249-249.
[2] 李凯, 张志远, 苏怀东, 向涵, 张伟. 一种可拆卸组装的腹腔镜手术器械在单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 250-250.
[3] 杨尹默, 陈依然, 田孝东. 努力提高腹腔镜胰十二指肠切除术的规范化水平[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 237-242.
[4] 张太平, 刘悦泽. 腹腔镜胰十二指肠切除术要点与原则[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 243-245.
[5] 王槐志, 孙丕绛, 崔上. 腹腔镜下胰十二指肠切除术的难点与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 246-248.
[6] 孟宇, 李金超, 刘金来, 刘晨, 王振勇. 新辅助化疗后LPD钩突切除中先动脉后静脉原则的安全性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 251-254.
[7] 宫向良, 刘征, 丁梅. 基于膜解剖D2+CME根治术治疗胃癌的近中期随访研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 267-270.
[8] 金田力, 袁文正, 付涛. 单孔腹腔镜右半结肠癌根治术后尿管拔除时机探讨[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 271-274.
[9] 杜彦斌, 黄涛, 寇天阔, 石英. 双镜联合根治术与腹腔镜根治术在早期结肠癌患者中的应用效果[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 275-278.
[10] 张聃, 王毅, 冯文迪, 方兴中. 完整结肠系膜切除术与传统根治术治疗结肠癌对患者生存期的影响观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 279-282.
[11] 唐浩, 梁平, 程千里, 徐小江, 曾凯, 文拨辉. 基于数字化微创技术对复杂性肝胆管结石患者胆道、肝静脉、门静脉解剖与变异情况及应用效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 291-294.
[12] 王东阳, 林琳, 娄熙彬. SII对局部进展期胃癌nCRT+腹腔镜胃癌根治术后并发症及预后的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 315-318.
[13] 吴鹏, 许维, 王壮, 郑世海, 宋劲松. 隧道法行腹腔镜下脾切除术的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 319-322.
[14] 聂彬, 赵铁军, 于云宝, 李欢, 谢林峻. 单孔加一孔腹腔镜手术与传统腹腔镜手术治疗乙状结肠癌的疗效与分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 330-333.
[15] 赵国栋, 陆锦俊, 许永强. 不同肠系膜下动脉分型的腹腔镜低位直肠前切除术临床效果及经验总结[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 334-337.
阅读次数
全文


摘要